about
VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) huma...
Read More57,226 XNAS Volume
XNAS 13 May, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
VivoSim Labs Inc. Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..